SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2frx'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1FK6_A_LNLA1201_1 (NON-SPECIFIC LIPID TRANSFER PROTEIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	VAL A 108 LEU A 111 ALA A 190 ALA A 147 ILE A 145	None	0.93A	1fk6A-2frxA: undetectable	1fk6A-2frxA: 11.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_E_THAE5_2 (LIVER CARBOXYLESTERASE I)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	3 / 3	PHE A 180 LEU A 146 LEU A 374	None	0.66A	1mx1E-2frxA: undetectable	1mx1E-2frxA: 21.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q0Y_H_MOIH401_1 (FAB 9B1, HEAVY CHAIN FAB 9B1, LIGHT CHAIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 7	TRP A 351 ILE A 340 LEU A 405 TRP A 397	None	1.13A	1q0yH-2frxA: undetectable 1q0yL-2frxA: undetectable	1q0yH-2frxA: 18.58 1q0yL-2frxA: 18.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RU9_H_ACTH611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 6	LEU A 64 TRP A 62 LEU A 86 PHE A 97	None	1.39A	1ru9H-2frxA: undetectable 1ru9L-2frxA: undetectable	1ru9H-2frxA: 18.85 1ru9L-2frxA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1RUK_L_ACTL611_0 (IMMUNOGLOBULIN IGG2A, HEAVY CHAIN IMMUNOGLOBULIN IGG2A, LIGHT CHAIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 6	LEU A 64 TRP A 62 LEU A 86 PHE A 97	None	1.46A	1rukH-2frxA: undetectable 1rukL-2frxA: undetectable	1rukH-2frxA: 18.85 1rukL-2frxA: 18.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1SQF_A_SAMA430_0 (SUN PROTEIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 127 GLY A 129 GLY A 177 ARG A 178 PRO A 196	None	0.90A	1sqfA-2frxA: 32.3	1sqfA-2frxA: 23.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_H_ASDH1224_1 (GLUTATHIONE S-TRANSFERASE A3)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 9	LEU A 357 LEU A 355 ALA A 344 LEU A 405 ALA A 401	None	1.07A	2vcvH-2frxA: 2.2	2vcvH-2frxA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VCV_I_ASDI1224_1 (GLUTATHIONE S-TRANSFERASE A3)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 9	LEU A 357 LEU A 355 ALA A 344 LEU A 405 ALA A 401	None	1.07A	2vcvI-2frxA: undetectable	2vcvI-2frxA: 21.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YGP_A_PCFA1213_0 (WNT INHIBITORY FACTOR 1)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ILE A 167 LEU A 46 ILE A 145 VAL A 108 PHE A 112	None	1.10A	2ygpA-2frxA: undetectable	2ygpA-2frxA: 16.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CJT_K_SAMK302_0 (RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	LEU A 452 GLY A 451 VAL A 430 LEU A 460 LEU A 442	None	1.28A	3cjtK-2frxA: 13.9	3cjtK-2frxA: 23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3FI0_P_TRPP1001_0 (TRYPTOPHANYL-TRNA SYNTHETASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 7	GLY A 129 ASP A 123 ILE A 145 GLN A 134	None	0.92A	3fi0P-2frxA: undetectable	3fi0P-2frxA: 21.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6V_A_SAMA465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	ALA A 125 PRO A 128 GLY A 129 ARG A 154 ASP A 194 PRO A 196	None	1.05A	3m6vA-2frxA: 38.2	3m6vA-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6V_A_SAMA465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	ALA A 125 PRO A 128 GLY A 129 ASP A 194 PRO A 196 LEU A 228	None	0.84A	3m6vA-2frxA: 38.2	3m6vA-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6V_A_SAMA465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 LYS A 131 ARG A 154 ASP A 194 PRO A 196	None	1.27A	3m6vA-2frxA: 38.2	3m6vA-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6V_B_SAMB465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	ALA A 125 PRO A 128 GLY A 129 ARG A 154 ASP A 194 PRO A 196	None	1.07A	3m6vB-2frxA: 38.2	3m6vB-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6V_B_SAMB465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	ALA A 125 PRO A 128 GLY A 129 ASP A 194 PRO A 196 LEU A 228	None	0.85A	3m6vB-2frxA: 38.2	3m6vB-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6V_B_SAMB465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 LYS A 131 ARG A 154 ASP A 194 PRO A 196	None	1.25A	3m6vB-2frxA: 38.2	3m6vB-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6W_A_SAMA465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 125 PRO A 128 GLY A 129 ARG A 154 PRO A 196	None	0.98A	3m6wA-2frxA: 38.1	3m6wA-2frxA: 35.33
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3M6W_A_SAMA465_0 (RRNA METHYLASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 125 PRO A 128 GLY A 129 PRO A 196 LEU A 228	None	0.70A	3m6wA-2frxA: 38.1	3m6wA-2frxA: 35.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N8X_A_NIMA701_2 (PROSTAGLANDIN G/H SYNTHASE 1)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	3 / 3	VAL A 243 SER A 245 LEU A 192	None	0.71A	3n8xA-2frxA: undetectable	3n8xA-2frxA: 24.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OKX_B_SAMB201_0 (YAEB-LIKE PROTEIN RPA0152)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	3 / 3	LYS A 377 ARG A 120 LYS A 310	None	1.43A	3okxA-2frxA: undetectable	3okxA-2frxA: 17.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3VN2_A_TLSA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	PHE A 180 ILE A 135 LEU A 111 LEU A 236 PHE A 188	None	1.18A	3vn2A-2frxA: undetectable	3vn2A-2frxA: 21.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_A_SAMA401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	7 / 12	PRO A 128 ASN A 148 SER A 151 GLY A 177 ASP A 194 PRO A 196 LEU A 228	None	0.75A	4fp9A-2frxA: 29.1	4fp9A-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_A_SAMA401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	7 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 GLY A 177 ASP A 194 PRO A 196	None	0.71A	4fp9A-2frxA: 29.1	4fp9A-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_A_SAMA401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 LYS A 131 SER A 151 ASP A 194 PRO A 196	None	1.00A	4fp9A-2frxA: 29.1	4fp9A-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_A_SAMA401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 LYS A 131 SER A 151 ASP A 194 PRO A 196 LEU A 228	None	1.07A	4fp9A-2frxA: 29.1	4fp9A-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_C_SAMC401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	7 / 12	PRO A 128 ASN A 148 SER A 151 GLY A 177 ASP A 194 PRO A 196 LEU A 228	None	0.75A	4fp9C-2frxA: 29.1	4fp9C-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_C_SAMC401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	7 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 GLY A 177 ASP A 194 PRO A 196	None	0.71A	4fp9C-2frxA: 29.1	4fp9C-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_C_SAMC401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 LYS A 131 SER A 151 ASP A 194 PRO A 196	None	1.00A	4fp9C-2frxA: 29.1	4fp9C-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_C_SAMC401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 LYS A 131 SER A 151 ASP A 194 PRO A 196 LEU A 228	None	1.08A	4fp9C-2frxA: 29.1	4fp9C-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_D_SAMD401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 ASN A 148 SER A 151 GLY A 177 PRO A 196 LEU A 228	None	0.74A	4fp9D-2frxA: 29.2	4fp9D-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_D_SAMD401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 ASP A 176 GLY A 177	None	1.10A	4fp9D-2frxA: 29.2	4fp9D-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_D_SAMD401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 GLY A 177 PRO A 196	None	0.61A	4fp9D-2frxA: 29.2	4fp9D-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_D_SAMD401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	PRO A 128 GLY A 129 LYS A 131 SER A 151 PRO A 196	None	0.89A	4fp9D-2frxA: 29.2	4fp9D-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_D_SAMD401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	PRO A 128 LYS A 131 SER A 151 PRO A 196 LEU A 228	None	1.06A	4fp9D-2frxA: 29.2	4fp9D-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_F_SAMF401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	7 / 12	PRO A 128 ASN A 148 SER A 151 GLY A 177 ASP A 194 PRO A 196 LEU A 228	None	0.75A	4fp9F-2frxA: 29.0	4fp9F-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_F_SAMF401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	7 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 GLY A 177 ASP A 194 PRO A 196	None	0.72A	4fp9F-2frxA: 29.0	4fp9F-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_F_SAMF401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 LYS A 131 SER A 151 ASP A 194 PRO A 196	None	1.00A	4fp9F-2frxA: 29.0	4fp9F-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FP9_F_SAMF401_0 (METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 LYS A 131 SER A 151 ASP A 194 PRO A 196 LEU A 228	None	1.07A	4fp9F-2frxA: 29.0	4fp9F-2frxA: 24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FZV_A_SAMA401_0 (PUTATIVE METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 ASN A 148 SER A 151 GLY A 177 PRO A 196 LEU A 228	None	0.73A	4fzvA-2frxA: 28.9	4fzvA-2frxA: 24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FZV_A_SAMA401_0 (PUTATIVE METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 ASP A 176 GLY A 177	None	1.15A	4fzvA-2frxA: 28.9	4fzvA-2frxA: 24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FZV_A_SAMA401_0 (PUTATIVE METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	6 / 12	PRO A 128 GLY A 129 ASN A 148 SER A 151 GLY A 177 PRO A 196	None	0.66A	4fzvA-2frxA: 28.9	4fzvA-2frxA: 24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FZV_A_SAMA401_0 (PUTATIVE METHYLTRANSFERASE NSUN4)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	PRO A 128 GLY A 129 LYS A 131 SER A 151 PRO A 196	None	0.94A	4fzvA-2frxA: 28.9	4fzvA-2frxA: 24.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKJ_B_SUZB201_1 (TRANSTHYRETIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 8	SER A 407 ALA A 344 LEU A 405 THR A 345	None	1.01A	4ikjA-2frxA: undetectable 4ikjB-2frxA: undetectable	4ikjA-2frxA: 17.16 4ikjB-2frxA: 17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKK_A_SUZA201_1 (TRANSTHYRETIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 8	ALA A 344 LEU A 405 THR A 345 SER A 407	None	0.95A	4ikkA-2frxA: undetectable 4ikkB-2frxA: undetectable	4ikkA-2frxA: 17.16 4ikkB-2frxA: 17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IKL_B_SUZB201_1 (TRANSTHYRETIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 8	SER A 407 ALA A 344 LEU A 405 THR A 345	None	0.90A	4iklA-2frxA: undetectable 4iklB-2frxA: undetectable	4iklA-2frxA: 17.16 4iklB-2frxA: 17.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5BPH_C_ACTC403_0 (D-ALANINE--D-ALANINE LIGASE)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 4	TYR A 464 GLY A 95 SER A 94 LEU A 93	None	1.44A	5bphC-2frxA: undetectable	5bphC-2frxA: 22.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WWS_A_SAMA501_0 (PUTATIVE METHYLTRANSFERASE NSUN6)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 127 PRO A 128 ASP A 176 GLY A 177 ASP A 194	None	1.05A	5wwsA-2frxA: 31.2	5wwsA-2frxA: 22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WWS_A_SAMA501_0 (PUTATIVE METHYLTRANSFERASE NSUN6)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 127 PRO A 128 GLY A 177 ASP A 194 LEU A 228	None	0.60A	5wwsA-2frxA: 31.2	5wwsA-2frxA: 22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5WWS_B_SAMB501_0 (PUTATIVE METHYLTRANSFERASE NSUN6)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 127 PRO A 128 ASP A 176 GLY A 177 ASP A 194	None	1.07A	5wwsB-2frxA: 31.1	5wwsB-2frxA: 22.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZVG_B_SAMB401_0 (389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	ALA A 125 PRO A 128 SER A 151 ARG A 178 PRO A 196	None	0.90A	5zvgB-2frxA: 34.6	5zvgB-2frxA: 24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZVG_B_SAMB401_0 (389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	5 / 12	PRO A 128 LYS A 131 SER A 151 ARG A 178 PRO A 196	None	1.06A	5zvgB-2frxA: 34.6	5zvgB-2frxA: 24.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_A_ECLA1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 7	ILE A 371 LEU A 374 ILE A 135 ALA A 235	None	0.80A	6b5vA-2frxA: undetectable 6b5vC-2frxA: undetectable	6b5vA-2frxA: 10.76 6b5vC-2frxA: 10.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_B_ECLB1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 7	ALA A 235 ILE A 371 LEU A 374 ILE A 135	None	0.78A	6b5vA-2frxA: undetectable 6b5vB-2frxA: undetectable	6b5vA-2frxA: 10.76 6b5vB-2frxA: 10.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_C_ECLC1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 7	ILE A 371 LEU A 374 ILE A 135 ALA A 235	None	0.81A	6b5vC-2frxA: undetectable 6b5vD-2frxA: undetectable	6b5vC-2frxA: 10.76 6b5vD-2frxA: 10.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5V_D_ECLD1001_1 (TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5)	2frx	HYPOTHETICAL PROTEIN YEBU (Escherichia coli)	4 / 7	ALA A 235 ILE A 371 LEU A 374 ILE A 135	None	0.80A	6b5vB-2frxA: undetectable 6b5vD-2frxA: undetectable	6b5vB-2frxA: 10.76 6b5vD-2frxA: 10.76

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1FK6_A_LNLA1201_1","NON-SPECIFIC LIPID TRANSFER PROTEIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"VAL A 108;LEU A 111;ALA A 190;ALA A 147;ILE A 145","None","0.93A","1fk6A-2frxA:undetectable","1fk6A-2frxA:11.69"],["1MX1_E_THAE5_2","LIVER CARBOXYLESTERASE I","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",3,"PHE A 180;LEU A 146;LEU A 374","None","0.66A","1mx1E-2frxA:undetectable","1mx1E-2frxA:21.54"],["1Q0Y_H_MOIH401_1","FAB 9B1, HEAVY CHAIN;FAB 9B1, LIGHT CHAIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"TRP A 351;ILE A 340;LEU A 405;TRP A 397","None","1.13A","1q0yH-2frxA:undetectable;1q0yL-2frxA:undetectable","1q0yH-2frxA:18.58;1q0yL-2frxA:18.72"],["1RU9_H_ACTH611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"LEU A  64;TRP A  62;LEU A  86;PHE A  97","None","1.39A","1ru9H-2frxA:undetectable;1ru9L-2frxA:undetectable","1ru9H-2frxA:18.85;1ru9L-2frxA:18.26"],["1RUK_L_ACTL611_0","IMMUNOGLOBULIN IGG2A, HEAVY CHAIN;IMMUNOGLOBULIN IGG2A, LIGHT CHAIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"LEU A  64;TRP A  62;LEU A  86;PHE A  97","None","1.46A","1rukH-2frxA:undetectable;1rukL-2frxA:undetectable","1rukH-2frxA:18.85;1rukL-2frxA:18.26"],["1SQF_A_SAMA430_0","SUN PROTEIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 127;GLY A 129;GLY A 177;ARG A 178;PRO A 196","None","0.90A","1sqfA-2frxA:32.3","1sqfA-2frxA:23.61"],["2VCV_H_ASDH1224_1","GLUTATHIONE S-TRANSFERASE A3","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"LEU A 357;LEU A 355;ALA A 344;LEU A 405;ALA A 401","None","1.07A","2vcvH-2frxA:2.2","2vcvH-2frxA:21.34"],["2VCV_I_ASDI1224_1","GLUTATHIONE S-TRANSFERASE A3","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"LEU A 357;LEU A 355;ALA A 344;LEU A 405;ALA A 401","None","1.07A","2vcvI-2frxA:undetectable","2vcvI-2frxA:21.34"],["2YGP_A_PCFA1213_0","WNT INHIBITORY FACTOR 1","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ILE A 167;LEU A  46;ILE A 145;VAL A 108;PHE A 112","None","1.10A","2ygpA-2frxA:undetectable","2ygpA-2frxA:16.20"],["3CJT_K_SAMK302_0","RIBOSOMAL PROTEIN L11 METHYLTRANSFERASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"LEU A 452;GLY A 451;VAL A 430;LEU A 460;LEU A 442","None","1.28A","3cjtK-2frxA:13.9","3cjtK-2frxA:23.19"],["3FI0_P_TRPP1001_0","TRYPTOPHANYL-TRNA SYNTHETASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"GLY A 129;ASP A 123;ILE A 145;GLN A 134","None","0.92A","3fi0P-2frxA:undetectable","3fi0P-2frxA:21.28"],["3M6V_A_SAMA465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"ALA A 125;PRO A 128;GLY A 129;ARG A 154;ASP A 194;PRO A 196","None","1.05A","3m6vA-2frxA:38.2","3m6vA-2frxA:35.33"],["3M6V_A_SAMA465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"ALA A 125;PRO A 128;GLY A 129;ASP A 194;PRO A 196;LEU A 228","None","0.84A","3m6vA-2frxA:38.2","3m6vA-2frxA:35.33"],["3M6V_A_SAMA465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;LYS A 131;ARG A 154;ASP A 194;PRO A 196","None","1.27A","3m6vA-2frxA:38.2","3m6vA-2frxA:35.33"],["3M6V_B_SAMB465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"ALA A 125;PRO A 128;GLY A 129;ARG A 154;ASP A 194;PRO A 196","None","1.07A","3m6vB-2frxA:38.2","3m6vB-2frxA:35.33"],["3M6V_B_SAMB465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"ALA A 125;PRO A 128;GLY A 129;ASP A 194;PRO A 196;LEU A 228","None","0.85A","3m6vB-2frxA:38.2","3m6vB-2frxA:35.33"],["3M6V_B_SAMB465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;LYS A 131;ARG A 154;ASP A 194;PRO A 196","None","1.25A","3m6vB-2frxA:38.2","3m6vB-2frxA:35.33"],["3M6W_A_SAMA465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 125;PRO A 128;GLY A 129;ARG A 154;PRO A 196","None","0.98A","3m6wA-2frxA:38.1","3m6wA-2frxA:35.33"],["3M6W_A_SAMA465_0","RRNA METHYLASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 125;PRO A 128;GLY A 129;PRO A 196;LEU A 228","None","0.70A","3m6wA-2frxA:38.1","3m6wA-2frxA:35.33"],["3N8X_A_NIMA701_2","PROSTAGLANDIN G\/H SYNTHASE 1","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",3,"VAL A 243;SER A 245;LEU A 192","None","0.71A","3n8xA-2frxA:undetectable","3n8xA-2frxA:24.41"],["3OKX_B_SAMB201_0","YAEB-LIKE PROTEIN RPA0152","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",3,"LYS A 377;ARG A 120;LYS A 310","None","1.43A","3okxA-2frxA:undetectable","3okxA-2frxA:17.45"],["3VN2_A_TLSA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"PHE A 180;ILE A 135;LEU A 111;LEU A 236;PHE A 188","None","1.18A","3vn2A-2frxA:undetectable","3vn2A-2frxA:21.04"],["4FP9_A_SAMA401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",7,"PRO A 128;ASN A 148;SER A 151;GLY A 177;ASP A 194;PRO A 196;LEU A 228","None","0.75A","4fp9A-2frxA:29.1","4fp9A-2frxA:24.27"],["4FP9_A_SAMA401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",7,"PRO A 128;GLY A 129;ASN A 148;SER A 151;GLY A 177;ASP A 194;PRO A 196","None","0.71A","4fp9A-2frxA:29.1","4fp9A-2frxA:24.27"],["4FP9_A_SAMA401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;LYS A 131;SER A 151;ASP A 194;PRO A 196","None","1.00A","4fp9A-2frxA:29.1","4fp9A-2frxA:24.27"],["4FP9_A_SAMA401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;LYS A 131;SER A 151;ASP A 194;PRO A 196;LEU A 228","None","1.07A","4fp9A-2frxA:29.1","4fp9A-2frxA:24.27"],["4FP9_C_SAMC401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",7,"PRO A 128;ASN A 148;SER A 151;GLY A 177;ASP A 194;PRO A 196;LEU A 228","None","0.75A","4fp9C-2frxA:29.1","4fp9C-2frxA:24.27"],["4FP9_C_SAMC401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",7,"PRO A 128;GLY A 129;ASN A 148;SER A 151;GLY A 177;ASP A 194;PRO A 196","None","0.71A","4fp9C-2frxA:29.1","4fp9C-2frxA:24.27"],["4FP9_C_SAMC401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;LYS A 131;SER A 151;ASP A 194;PRO A 196","None","1.00A","4fp9C-2frxA:29.1","4fp9C-2frxA:24.27"],["4FP9_C_SAMC401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;LYS A 131;SER A 151;ASP A 194;PRO A 196;LEU A 228","None","1.08A","4fp9C-2frxA:29.1","4fp9C-2frxA:24.27"],["4FP9_D_SAMD401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;ASN A 148;SER A 151;GLY A 177;PRO A 196;LEU A 228","None","0.74A","4fp9D-2frxA:29.2","4fp9D-2frxA:24.27"],["4FP9_D_SAMD401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;ASN A 148;SER A 151;ASP A 176;GLY A 177","None","1.10A","4fp9D-2frxA:29.2","4fp9D-2frxA:24.27"],["4FP9_D_SAMD401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;ASN A 148;SER A 151;GLY A 177;PRO A 196","None","0.61A","4fp9D-2frxA:29.2","4fp9D-2frxA:24.27"],["4FP9_D_SAMD401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"PRO A 128;GLY A 129;LYS A 131;SER A 151;PRO A 196","None","0.89A","4fp9D-2frxA:29.2","4fp9D-2frxA:24.27"],["4FP9_D_SAMD401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"PRO A 128;LYS A 131;SER A 151;PRO A 196;LEU A 228","None","1.06A","4fp9D-2frxA:29.2","4fp9D-2frxA:24.27"],["4FP9_F_SAMF401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",7,"PRO A 128;ASN A 148;SER A 151;GLY A 177;ASP A 194;PRO A 196;LEU A 228","None","0.75A","4fp9F-2frxA:29.0","4fp9F-2frxA:24.27"],["4FP9_F_SAMF401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",7,"PRO A 128;GLY A 129;ASN A 148;SER A 151;GLY A 177;ASP A 194;PRO A 196","None","0.72A","4fp9F-2frxA:29.0","4fp9F-2frxA:24.27"],["4FP9_F_SAMF401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;LYS A 131;SER A 151;ASP A 194;PRO A 196","None","1.00A","4fp9F-2frxA:29.0","4fp9F-2frxA:24.27"],["4FP9_F_SAMF401_0","METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;LYS A 131;SER A 151;ASP A 194;PRO A 196;LEU A 228","None","1.07A","4fp9F-2frxA:29.0","4fp9F-2frxA:24.27"],["4FZV_A_SAMA401_0","PUTATIVE METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;ASN A 148;SER A 151;GLY A 177;PRO A 196;LEU A 228","None","0.73A","4fzvA-2frxA:28.9","4fzvA-2frxA:24.12"],["4FZV_A_SAMA401_0","PUTATIVE METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;ASN A 148;SER A 151;ASP A 176;GLY A 177","None","1.15A","4fzvA-2frxA:28.9","4fzvA-2frxA:24.12"],["4FZV_A_SAMA401_0","PUTATIVE METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",6,"PRO A 128;GLY A 129;ASN A 148;SER A 151;GLY A 177;PRO A 196","None","0.66A","4fzvA-2frxA:28.9","4fzvA-2frxA:24.12"],["4FZV_A_SAMA401_0","PUTATIVE METHYLTRANSFERASE NSUN4","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"PRO A 128;GLY A 129;LYS A 131;SER A 151;PRO A 196","None","0.94A","4fzvA-2frxA:28.9","4fzvA-2frxA:24.12"],["4IKJ_B_SUZB201_1","TRANSTHYRETIN;TRANSTHYRETIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"SER A 407;ALA A 344;LEU A 405;THR A 345","None","1.01A","4ikjA-2frxA:undetectable;4ikjB-2frxA:undetectable","4ikjA-2frxA:17.16;4ikjB-2frxA:17.16"],["4IKK_A_SUZA201_1","TRANSTHYRETIN;TRANSTHYRETIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"ALA A 344;LEU A 405;THR A 345;SER A 407","None","0.95A","4ikkA-2frxA:undetectable;4ikkB-2frxA:undetectable","4ikkA-2frxA:17.16;4ikkB-2frxA:17.16"],["4IKL_B_SUZB201_1","TRANSTHYRETIN;TRANSTHYRETIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"SER A 407;ALA A 344;LEU A 405;THR A 345","None","0.90A","4iklA-2frxA:undetectable;4iklB-2frxA:undetectable","4iklA-2frxA:17.16;4iklB-2frxA:17.16"],["5BPH_C_ACTC403_0","D-ALANINE--D-ALANINE LIGASE","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"TYR A 464;GLY A  95;SER A  94;LEU A  93","None","1.44A","5bphC-2frxA:undetectable","5bphC-2frxA:22.22"],["5WWS_A_SAMA501_0","PUTATIVE METHYLTRANSFERASE NSUN6","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 127;PRO A 128;ASP A 176;GLY A 177;ASP A 194","None","1.05A","5wwsA-2frxA:31.2","5wwsA-2frxA:22.56"],["5WWS_A_SAMA501_0","PUTATIVE METHYLTRANSFERASE NSUN6","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 127;PRO A 128;GLY A 177;ASP A 194;LEU A 228","None","0.60A","5wwsA-2frxA:31.2","5wwsA-2frxA:22.56"],["5WWS_B_SAMB501_0","PUTATIVE METHYLTRANSFERASE NSUN6","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 127;PRO A 128;ASP A 176;GLY A 177;ASP A 194","None","1.07A","5wwsB-2frxA:31.1","5wwsB-2frxA:22.56"],["5ZVG_B_SAMB401_0","389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"ALA A 125;PRO A 128;SER A 151;ARG A 178;PRO A 196","None","0.90A","5zvgB-2frxA:34.6","5zvgB-2frxA:24.69"],["5ZVG_B_SAMB401_0","389AA LONG HYPOTHETICAL NUCLEOLAR PROTEIN","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",5,"PRO A 128;LYS A 131;SER A 151;ARG A 178;PRO A 196","None","1.06A","5zvgB-2frxA:34.6","5zvgB-2frxA:24.69"],["6B5V_A_ECLA1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"ILE A 371;LEU A 374;ILE A 135;ALA A 235","None","0.80A","6b5vA-2frxA:undetectable;6b5vC-2frxA:undetectable","6b5vA-2frxA:10.76;6b5vC-2frxA:10.76"],["6B5V_B_ECLB1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"ALA A 235;ILE A 371;LEU A 374;ILE A 135","None","0.78A","6b5vA-2frxA:undetectable;6b5vB-2frxA:undetectable","6b5vA-2frxA:10.76;6b5vB-2frxA:10.76"],["6B5V_C_ECLC1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"ILE A 371;LEU A 374;ILE A 135;ALA A 235","None","0.81A","6b5vC-2frxA:undetectable;6b5vD-2frxA:undetectable","6b5vC-2frxA:10.76;6b5vD-2frxA:10.76"],["6B5V_D_ECLD1001_1","TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5;TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL SUBFAMILY V MEMBER 5","2frx","HYPOTHETICAL PROTEIN YEBU","Escherichia coli",4,"ALA A 235;ILE A 371;LEU A 374;ILE A 135","None","0.80A","6b5vB-2frxA:undetectable;6b5vD-2frxA:undetectable","6b5vB-2frxA:10.76;6b5vD-2frxA:10.76"]]